A record number of U.S.-based marijuana companies are turning to Canada to fund aggressive expansion in the United States and globally. The companies, which face investment constraints in the United States, are being lured by Canada’s cannabis-friendly capital markets...
Matt Lamers
Matt Lamers's Latest Posts
Ontario signs up first marijuana accessories suppliers
The Ontario Cannabis Store – the province’s government-operated wholesaler and online retailer – inked deals with 10 accessories suppliers to provide products to offer alongside recreational marijuana when sales begin next month.
Marlboro maker ‘evaluating opportunities’ in cannabis industry
Altria Group, one of the largest tobacco companies in North America, is assessing its market opportunities in the cannabis industry. The entry of Altria - owner of Marlboro maker Philip Morris USA and an investor in alcohol giant Anheuser-Busch InBev - would be...
5 ways to market your cannabis company in Canada without breaking the law
Canada's legal cannabis industry means big business for the country and its entrepreneurs. But when it comes to launching brands with a bang come Oct. 17, governments haven't made it easy, with a quagmire of overlapping laws and regulations that restrict advertising,...
Five Questions with Richard Carleton, CEO of the Canadian Securities Exchange
Richard Carleton’s involvement in medical cannabis dates to spring 2014. That’s when medicinal cannabis companies in Canada, buoyed by new federal regulations, first turned to the public markets for capital to grow their businesses. They found the incumbent exchanges...
Analyst says Cronos stock swings ‘overdone,’ calls deception allegations ‘unfounded’
Shares of Cronos Group were punished by investors this week after the Ontario-based licensed producer of cannabis was targeted by short-seller Andrew Left of Citron Research - but at least one analyst called the wild swing "overdone." Citron's report, issued Aug....
Canadian cannabis prices continue falling ahead of legalization
The average combined price for nonmedical and medical cannabis has fallen 10.6% since the first quarter of 2016, according to new data from Statistics Canada. The latest data from StatsCan pegs the average combined cost of nonmedical and medical cannabis at 6.74...
Argentina medical school’s cannabis course could open MMJ business opportunities
The medical school at Argentina’s Universidad Nacional del Sur – or the National University of the South – will offer a course on the use and prescription of medicinal cannabis to third-year students.
New Zealand grants first medical cannabis business license
New Zealand’s health ministry has given a private company permission to cultivate medical cannabis – representing a first in the country and a milestone for the industry.
Lack of ‘meaningful’ consultation hinders First Nations’ participation in Canada’s cannabis industry
Businesses with identified First Nations affiliations make up only 5% of Canada’s licensed cannabis producers, a fact that indigenous leaders blame on the federal government’s failure to adequately consult with communities over the legalization of marijuana.
Germany turns to Netherlands for more medical marijuana
The Netherlands has agreed to significantly increase shipments of medical cannabis to Germany to help the country cope with soaring demand.
Canada’s licensed marijuana producers and applicants soar past 700
With cannabis legalization around the corner in Canada, more companies than ever are lining up to be licensed producers (LPs).
On top of the 115 companies that have already been granted licenses, 588 applicants were waiting in the LP pipeline as of early August, according to data provided by Health Canada.













